Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2008, p. 1204-1205, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01320-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Escherichia coli Isolate Coproducing 16S rRNA Methylase and CTX-M-Type Extended-Spectrum β-Lactamase Isolated from an Outpatient in the United States

LETTER
High-level resistance to aminoglycosides mediated by the production
of 16S rRNA methylase among various gram-negative pathogens
has been increasingly reported (
4). Six 16S rRNA methylase enzymes
have been identified: RmtA to RmtD, ArmA, and NpmA (
4,
9). We
recently described the emergence of ArmA among
Acinetobacter baumannii strains in North America (
3). Here, we report the
isolation of an
Escherichia coli strain coproducing 16S rRNA
methylase RmtB and extended-spectrum β-lactamase (ESBL)
CTX-M-65 from an ambulatory female with a history of sickle-cell
anemia.
E. coli grew in a urine culture ordered as part of her
evaluation for chronic kidney disease. A review of the records
indicated that she had been hospitalized briefly 4 months earlier,
but the urine culture did not grow
E. coli during or after that
hospitalization. This is the first instance in which RmtB has
been shown to be encoded on the same plasmid as an ESBL.
The isolate, E. coli ECRB1, was highly resistant to cefotaxime (MIC, 64 µg/ml) and gentamicin, tobramycin, and amikacin (MICs, >256 µg/ml) but was susceptible to trimethoprim-sulfamethoxazole and ciprofloxacin by Etest (AB Biodisk, Solna, Sweden). Transconjugants were obtained by the broth mating method on Luria-Bertani plates containing 50 µg of rifampin/ml and 50 µg of amikacin/ml by using E. coli XL1-Blue Rifr as the recipient. Transformants of E. coli DH10B were obtained on Luria-Bertani plates containing 50 µg of amikacin/ml following electroporation with plasmids purified from the parental strain. The MICs of cefotaxime (96 µg/ml) and the three aminoglycosides (
128 µg/ml) were high for both the transconjugant and transformant strains. The results of PCR analysis of whole-cell lysates for CTX-M genes (6) were positive for both strains. Direct sequencing of the entire structural gene amplified from the transformant confirmed it to encode CTX-M-65, a variant of CTX-M-14. Multiplex PCR analysis of the transconjugant and transformant strains for 16S rRNA methylase genes (4) revealed the presence of rmtB. The results of PCR analysis for qepA, a quinolone efflux pump gene reported to be carried on the same plasmid as rmtB (10), were negative for the transconjugant and transformant strains.
A 2.9-kb BamHI insert containing rmtB could be cloned from the transformant into vector pBCSK(–) (Stratagene, La Jolla, CA) with E. coli DH10B as the host. This plasmid conferred a high level of resistance to all three aminoglycosides tested (MICs, >256 µg/ml). Full sequencing of this insert revealed a genetic arrangement similar to those reported earlier (5, 10) in that the insert contained blaTEM-1 as part of Tn3 upstream from rmtB (Fig. 1). However, the putative transposase gene previously found downstream of rmtB was replaced by the 3' end of another transposase gene comprising IS26.
CTX-M-type ESBLs are increasingly associated with community-acquired
E. coli infections throughout the world, including the United
States (
2,
8).
rmtB has been found in strains carrying
blaCTX-M but, unlike
armA (
1,
7,
11), on a separate plasmid from
blaCTX-M.
Our findings indicate, however, that
rmtB may be captured by
the same conjugative plasmid carrying
blaCTX-M. The spread of
such multidrug resistance plasmids among
E. coli strains has
a potential impact on the empirical management of complicated
urinary tract infections that may be treated initially with
cephalosporins and aminoglycosides.

Nucleotide sequence accession number.
The sequences determined in this work have been deposited in
GenBank under accession no. EU213261 and EU213262.

ACKNOWLEDGMENTS
Y.D. is supported by NIH training grant T32 AI007333. D.L.P.
has received prior research funding from Pfizer, Elan, Merck,
and AstraZeneca and is supported in part by NIH research grant
R01 AI070896.

FOOTNOTES

Published ahead of print on 14 January 2008.


REFERENCES
1 - Bogaerts, P., M. Galimand, C. Bauraing, A. Deplano, R. Vanhoof, R. De Mendonca, H. Rodriguez-Villalobos, M. Struelens, and Y. Glupczynski. 2007. Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J. Antimicrob. Chemother. 59:459-464.[Abstract/Free Full Text]
2 - Doi, Y., J. Adams, A. O'Keefe, Z. Quereshi, L. Ewan, and D. L. Paterson. 2007. Community-acquired extended-spectrum β-lactamase producers, United States. Emerg. Infect. Dis. 13:1121-1123.[Medline]
3 - Doi, Y., J. M. Adams, K. Yamane, and D. L. Paterson. 2007. Identification of 16S rRNA methylase-producing Acinetobacter baumanii clinical strains in North America. Antimicrob. Agents Chemother. 51:4209-4210.[Abstract/Free Full Text]
4 - Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94.[CrossRef][Medline]
5 - Doi, Y., K. Yokoyama, K. Yamane, J. Wachino, N. Shibata, T. Yagi, K. Shibayama, H. Kato, and Y. Arakawa. 2004. Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob. Agents Chemother. 48:491-496.[Abstract/Free Full Text]
6 - Edelstein, M., M. Pimkin, I. Palagin, I. Edelstein, and L. Stratchounski. 2003. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47:3724-3732.[Abstract/Free Full Text]
7 - Galimand, M., S. Sabtcheva, P. Courvalin, and T. Lambert. 2005. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob. Agents Chemother. 49:2949-2953.[Abstract/Free Full Text]
8 - Livermore, D. M., R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.[Abstract/Free Full Text]
9 - Wachino, J. I., K. Shibayama, H. Kurokawa, K. Kimura, K. Yamane, S. Suzuki, N. Shibata, Y. Ike, and Y. Arakawa. 2007. Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides. Antimicrob. Agents Chemother. 51:4401-4409.[Abstract/Free Full Text]
10 - Yamane, K., J. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.[Abstract/Free Full Text]
11 - Yan, J. J., J. J. Wu, W. C. Ko, S. H. Tsai, C. L. Chuang, H. M. Wu, Y. J. Lu, and J. D. Li. 2004. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J. Antimicrob. Chemother. 54:1007-1012.[Abstract/Free Full Text]
| | | | | |
Yohei Doi*
Jennifer M. Adams-Haduch
Division of Infectious Diseases University of Pittsburgh Medical Center Pittsburgh, Pennsylvania
David L. Paterson
University of Queensland Royal Brisbane and Women's Hospital Brisbane, Australia
|
| | | | | |
* Phone: (412) 648-6401, Fax: (412) 648-6399, E-mail: doiy{at}dom.pitt.edu |
Antimicrobial Agents and Chemotherapy, March 2008, p. 1204-1205, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01320-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yuan, L., Liu, J.-H., Hu, G.-Z., Pan, Y.-S., Liu, Z.-M., Mo, J., Wei, Y.-J.
(2009). Molecular characterization of extended-spectrum {beta}-lactamase-producing Escherichia coli isolates from chickens in Henan Province, China. J Med Microbiol
58: 1449-1453
[Abstract]
[Full Text]
-
Yin, J., Cheng, J., Sun, Z., Ye, Y., Gao, Y.-F., Li, J.-B., Zhang, X.-J.
(2009). Characterization of two plasmid-encoded cefotaximases found in clinical Escherichia coli isolates: CTX-M-65 and a novel enzyme, CTX-M-87. J Med Microbiol
58: 811-815
[Abstract]
[Full Text]